Pharmacy-focused quick commerce startup Rio Health has secured $4.5 million, or about Rs 43 crore, in a pre-Series A funding round led by Version One Ventures, as investors continue to back faster, tech-enabled healthcare delivery in one of India's most competitive consumer internet categories.
The all-equity round also saw participation from existing backers Xeed Ventures, Good Capital and Amplify. For Rio Health, the fresh capital is intended to do more than simply extend runway. The company says it will use the money to widen its footprint across Delhi NCR, add 12 more dark stores, and strengthen the technology that powers ordering, inventory management and last-mile delivery.
Founded by Ankur Agrawal and Amit Ahuja, Rio Health has built its proposition around delivering medicines and healthcare essentials within 20 to 30 minutes. The startup has leaned heavily on convenience and accessibility, allowing customers to place orders by typing or speaking in Hindi, English or Hinglish, or by uploading a photograph of a prescription. Its AI system then identifies the prescribed medicines and creates an order, which is later verified by a licensed pharmacist before fulfilment.
That combination of speed and compliance is central to Rio Health's pitch in a category where operational complexity is significantly higher than in grocery quick commerce. Medicines cannot be treated like standard consumer goods: licensed entities, prescription checks, storage controls and tighter inventory management are all essential. Rio Health says its model is designed to address those requirements while still offering the speed that urban consumers have come to expect from quick commerce.
The startup currently processes more than 30,000 orders a month, with an average order value of Rs 600 to Rs 700. It says nearly 80% of those orders come from repeat customers, a sign that the service is building habitual usage rather than one-off demand. Rio Health also claims access to more than 20,000 stock keeping units, while long-tail medicines are sourced through its distributor network when they are not held in its own stores.
Its dark stores operate within a radius of roughly three kilometres, and the company says it uses neighbourhood-level demand data to forecast medicine requirements and stock each location accordingly. That localised inventory planning is increasingly important in pharmacy commerce, where stockouts can quickly erode trust and where overstocking can create waste, especially for products with tighter shelf-life or slower demand cycles.
"This funding will help us strengthen our technology, improve how we predict neighbourhood-level demand, and make reliable medicine delivery available to many more customers across Delhi NCR," said cofounder Ankur Agrawal.
Rio Health had previously raised Rs 19.2 crore across earlier funding rounds. The latest infusion takes its total funding to Rs 62.2 crore, or about $6.5 million. The company's next milestone is ambitious: it is targeting annual recurring revenue of more than Rs 150 crore over the next nine to 12 months, a sharp scale-up that would depend on both geographic expansion and sustained order frequency.
The fundraise lands at a time when quick commerce in India is moving beyond groceries and into higher-value, more regulated categories. The broader market is expected to become a $30 billion to $40 billion opportunity over the next three to five years, while quick commerce players are projected to clock $68 billion in gross merchandise value by 2031, up from $8.3 billion in 2026, according to the figures cited in the source material. That trajectory has encouraged major platforms such as Zepto, Blinkit and Swiggy Instamart to explore 10-minute medicine delivery as they look for new growth engines.
But the pharmacy segment is not simply another extension of grocery quick commerce. The regulatory burden is heavier, the fulfilment chain is more sensitive and the consequences of errors are more serious. That has created room for specialised startups like Rio Health, which are building around compliance as much as convenience.
The competitive landscape is also beginning to attract larger rounds for category specialists. Plazza, which operates technology-enabled neighbourhood pharmacies, raised $15 million in July 2026 to strengthen its AI-led inventory systems and expand beyond its two Bengaluru stores. Against that backdrop, Rio Health's latest raise underscores investor conviction that pharmacy quick commerce can emerge as a distinct and defensible business, provided operators can balance speed, trust and regulatory discipline.
For now, Rio Health is betting that deeper local coverage, better forecasting and a more automated ordering experience will help it capture a larger share of Delhi NCR's medicine demand. If it can execute on those plans, the startup could become one of the more closely watched names in India's fast-evolving healthcare commerce market.